Viral Resistance in Hepatitis C Virus Genotype 1-Infected Patients Receiving the NS3 Protease Inhibitor Faldaprevir (BI 201335) in a Phase 1b Multiple-Rising-Dose Study
Berger, K. L., Lagace, L., Triki, I., Cartier, M., Marquis, M., Lawetz, C., Bethell, R., Scherer, J., Kukolj, G.Volume:
57
Language:
english
Journal:
Antimicrobial Agents and Chemotherapy
DOI:
10.1128/AAC.00822-13
Date:
October, 2013
File:
PDF, 263 KB
english, 2013